Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

A high-throughput clinical assay for testing drug facilitation of exposure therapy.

Rodebaugh TL, Levinson CA, Lenze EJ.

Depress Anxiety. 2013 Jul;30(7):631-7. doi: 10.1002/da.22047. Epub 2013 Jan 2.

2.

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW.

Arch Gen Psychiatry. 2006 Mar;63(3):298-304.

PMID:
16520435
3.

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M.

Arch Gen Psychiatry. 2004 Nov;61(11):1136-44.

PMID:
15520361
4.

Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.

Hofmann SG, Carpenter JK, Otto MW, Rosenfield D, Smits JA, Pollack MH.

Contemp Clin Trials. 2015 Jul;43:223-30. doi: 10.1016/j.cct.2015.06.015. Epub 2015 Jun 23.

5.

D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.

Smits JA, Rosenfield D, Otto MW, Marques L, Davis ML, Meuret AE, Simon NM, Pollack MH, Hofmann SG.

J Psychiatr Res. 2013 Oct;47(10):1455-61. doi: 10.1016/j.jpsychires.2013.06.020. Epub 2013 Jul 16.

6.

D-cycloserine enhances generalization of fear extinction in children.

Byrne SP, Rapee RM, Richardson R, Malhi GS, Jones M, Hudson JL.

Depress Anxiety. 2015 Jun;32(6):408-14. doi: 10.1002/da.22356. Epub 2015 Mar 10.

PMID:
25775435
7.

A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.

de Kleine RA, Hendriks GJ, Kusters WJ, Broekman TG, van Minnen A.

Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. Epub 2012 Apr 4.

PMID:
22480663
8.

A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.

Norberg MM, Krystal JH, Tolin DF.

Biol Psychiatry. 2008 Jun 15;63(12):1118-26. doi: 10.1016/j.biopsych.2008.01.012. Epub 2008 Mar 7.

PMID:
18313643
9.

A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.

Guastella AJ, Dadds MR, Lovibond PF, Mitchell P, Richardson R.

J Psychiatr Res. 2007 Sep;41(6):466-71. Epub 2006 Jul 10.

PMID:
16828803
10.

D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.

Andersson E, Hedman E, Enander J, Radu Djurfeldt D, Ljótsson B, Cervenka S, Isung J, Svanborg C, Mataix-Cols D, Kaldo V, Andersson G, Lindefors N, Rück C.

JAMA Psychiatry. 2015 Jul;72(7):659-67. doi: 10.1001/jamapsychiatry.2015.0546.

PMID:
25970252
11.

A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.

Guastella AJ, Richardson R, Lovibond PF, Rapee RM, Gaston JE, Mitchell P, Dadds MR.

Biol Psychiatry. 2008 Mar 15;63(6):544-9. doi: 10.1016/j.biopsych.2007.11.011. Epub 2008 Jan 7.

PMID:
18179785
12.

D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.

Smits JA, Rosenfield D, Otto MW, Powers MB, Hofmann SG, Telch MJ, Pollack MH, Tart CD.

Biol Psychiatry. 2013 Jun 1;73(11):1054-8. doi: 10.1016/j.biopsych.2012.12.009. Epub 2013 Jan 16.

13.

Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.

de Kleine RA, Smits JA, Hendriks GJ, Becker ES, van Minnen A.

J Anxiety Disord. 2015 Aug;34:63-7. doi: 10.1016/j.janxdis.2015.06.005. Epub 2015 Jun 14.

PMID:
26121495
14.

Augmentation of exposure therapy with post-session administration of D-cycloserine.

Tart CD, Handelsman PR, Deboer LB, Rosenfield D, Pollack MH, Hofmann SG, Powers MB, Otto MW, Smits JA.

J Psychiatr Res. 2013 Feb;47(2):168-74. doi: 10.1016/j.jpsychires.2012.09.024. Epub 2012 Oct 23.

15.

D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.

Hofmann SG, Smits JA, Rosenfield D, Simon N, Otto MW, Meuret AE, Marques L, Fang A, Tart C, Pollack MH.

Am J Psychiatry. 2013 Jul;170(7):751-8. doi: 10.1176/appi.ajp.2013.12070974.

16.

Sleep quality predicts treatment outcome in CBT for social anxiety disorder.

Zalta AK, Dowd S, Rosenfield D, Smits JA, Otto MW, Simon NM, Meuret AE, Marques L, Hofmann SG, Pollack MH.

Depress Anxiety. 2013 Nov;30(11):1114-20. doi: 10.1002/da.22170. Epub 2013 Aug 26.

17.

D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.

Levinson CA, Rodebaugh TL, Fewell L, Kass AE, Riley EN, Stark L, McCallum K, Lenze EJ.

J Clin Psychiatry. 2015 Jun;76(6):e787-93. doi: 10.4088/JCP.14m09299.

18.

Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.

Nave AM, Tolin DF, Stevens MC.

J Clin Psychiatry. 2012 Sep;73(9):1179-86. doi: 10.4088/JCP.11m07564.

PMID:
23059145
19.

A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects.

Watson BJ, Wilson S, Griffin L, Kalk NJ, Taylor LG, Munafò MR, Lingford-Hughes AR, Nutt DJ.

Psychopharmacology (Berl). 2011 Jul;216(1):121-9. doi: 10.1007/s00213-011-2199-2. Epub 2011 Feb 12.

PMID:
21318564
20.

D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.

Difede J, Cukor J, Wyka K, Olden M, Hoffman H, Lee FS, Altemus M.

Neuropsychopharmacology. 2014 Apr;39(5):1052-8. doi: 10.1038/npp.2013.317. Epub 2013 Nov 12.

Supplemental Content

Support Center